358 related articles for article (PubMed ID: 12928036)
1. Molecular mechanisms modulating muscle mass.
Glass DJ
Trends Mol Med; 2003 Aug; 9(8):344-50. PubMed ID: 12928036
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle hypertrophy and atrophy signaling pathways.
Glass DJ
Int J Biochem Cell Biol; 2005 Oct; 37(10):1974-84. PubMed ID: 16087388
[TBL] [Abstract][Full Text] [Related]
3. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.
Stitt TN; Drujan D; Clarke BA; Panaro F; Timofeyva Y; Kline WO; Gonzalez M; Yancopoulos GD; Glass DJ
Mol Cell; 2004 May; 14(3):395-403. PubMed ID: 15125842
[TBL] [Abstract][Full Text] [Related]
4. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy.
Glass DJ
Nat Cell Biol; 2003 Feb; 5(2):87-90. PubMed ID: 12563267
[TBL] [Abstract][Full Text] [Related]
5. Molecular signaling pathways regulating muscle proteolysis during atrophy.
Franch HA; Price SR
Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):271-5. PubMed ID: 15809529
[TBL] [Abstract][Full Text] [Related]
6. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
7. Signaling pathways perturbing muscle mass.
Glass DJ
Curr Opin Clin Nutr Metab Care; 2010 May; 13(3):225-9. PubMed ID: 20397318
[TBL] [Abstract][Full Text] [Related]
8. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
[TBL] [Abstract][Full Text] [Related]
9. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
Glass DJ
Curr Top Microbiol Immunol; 2010; 346():267-78. PubMed ID: 20593312
[TBL] [Abstract][Full Text] [Related]
10. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.
Sandri M; Sandri C; Gilbert A; Skurk C; Calabria E; Picard A; Walsh K; Schiaffino S; Lecker SH; Goldberg AL
Cell; 2004 Apr; 117(3):399-412. PubMed ID: 15109499
[TBL] [Abstract][Full Text] [Related]
11. UBR5 is a novel E3 ubiquitin ligase involved in skeletal muscle hypertrophy and recovery from atrophy.
Seaborne RA; Hughes DC; Turner DC; Owens DJ; Baehr LM; Gorski P; Semenova EA; Borisov OV; Larin AK; Popov DV; Generozov EV; Sutherland H; Ahmetov II; Jarvis JC; Bodine SC; Sharples AP
J Physiol; 2019 Jul; 597(14):3727-3749. PubMed ID: 31093990
[TBL] [Abstract][Full Text] [Related]
12. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway.
Latres E; Amini AR; Amini AA; Griffiths J; Martin FJ; Wei Y; Lin HC; Yancopoulos GD; Glass DJ
J Biol Chem; 2005 Jan; 280(4):2737-44. PubMed ID: 15550386
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading.
Nakao R; Hirasaka K; Goto J; Ishidoh K; Yamada C; Ohno A; Okumura Y; Nonaka I; Yasutomo K; Baldwin KM; Kominami E; Higashibata A; Nagano K; Tanaka K; Yasui N; Mills EM; Takeda S; Nikawa T
Mol Cell Biol; 2009 Sep; 29(17):4798-811. PubMed ID: 19546233
[TBL] [Abstract][Full Text] [Related]
15. Molecular determinants of skeletal muscle mass: getting the "AKT" together.
Nader GA
Int J Biochem Cell Biol; 2005 Oct; 37(10):1985-96. PubMed ID: 16125108
[TBL] [Abstract][Full Text] [Related]
16. eIF3-f function in skeletal muscles: to stand at the crossroads of atrophy and hypertrophy.
Csibi A; Tintignac LA; Leibovitch MP; Leibovitch SA
Cell Cycle; 2008 Jun; 7(12):1698-701. PubMed ID: 18583931
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of MuRF1 and MAFbx participates to muscle wasting upon gentamicin-induced acute kidney injury.
Aniort J; Polge C; Claustre A; Combaret L; Béchet D; Attaix D; Heng AE; Taillandier D
Int J Biochem Cell Biol; 2016 Oct; 79():505-516. PubMed ID: 27102410
[TBL] [Abstract][Full Text] [Related]
18. Balanced Diet-Fed Fat-1 Transgenic Mice Exhibit Lower Hindlimb Suspension-Induced Soleus Muscle Atrophy.
Marzuca-Nassr GN; Murata GM; Martins AR; Vitzel KF; Crisma AR; Torres RP; Mancini-Filho J; Kang JX; Curi R
Nutrients; 2017 Oct; 9(10):. PubMed ID: 28984836
[TBL] [Abstract][Full Text] [Related]
19. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
[TBL] [Abstract][Full Text] [Related]
20. MAFbx/Atrogin-1 expression is a poor index of muscle proteolysis.
Attaix D; Baracos VE
Curr Opin Clin Nutr Metab Care; 2010 May; 13(3):223-4. PubMed ID: 20393275
[No Abstract] [Full Text] [Related]
[Next] [New Search]